Search Within

Principal Biostatisticians

  1. "Hematological Oncology"
Formats
  1. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Epidemiology and Biostatistics (4)
  4. Hematologic Malignancies, Division of (4)
  5. Lymphoma (4)
  6. Population Sciences Research Program (3)

More Groups

People
  1. Esther Drill (4)
  2. Matthew Matasar (3)
  3. Steven Horwitz (3)
  4. Ahmet Dogan (2)
  5. Alison Moskowitz (2)
  6. Anita Kumar (2)

More People

Years
  1. 2021 (2)
  2. 2019 (2)
Publications
  1. Hematological Oncology (4)
Publishers
  1. Wiley Blackwell (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Real‐world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Matasar, M. J.; Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save